Clinical trial
Cardiopulmonary Exercise Test Predicts Long-term Survival and Positive Response to Cardiac Resynchronization Therapy.
NCT03870074 is registered in ClinicalTrials.gov with National Institute of Cardiology, Warsaw, Poland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiopulmonary Exercise Test Predicts Long-term Survival and Positive Response to Cardiac Resynchronization Therapy.
- Lead sponsor
- National Institute of Cardiology, Warsaw, Poland
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- October 31, 2017
- Enrollment
- 122 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure with reduced ejection fraction